Literature DB >> 2169517

Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines.

O Satoh1, M Umeda, H Imai, H Tunoo, K Inoue.   

Abstract

More than 90% of lipids of hepatitis B virus surface antigen (HBsAg) particles produced by two human hepatoma cell lines (huGK-14 and PLC/PRF/5) were composed of phospholipids, with phosphatidylcholine being the dominant component, accounting for more than 80% of total membrane lipids. Analysis of subclass compositions of phospholipids of HBsAg particles and the host cell lines revealed that 1,2-diacyl glycerophosphocholine was preferentially incorporated into the membrane of the HBsAg particles, although both host cell lines contained extremely high concentrations (more than 60% of total phospholipids) of ether-linked phospholipids. Phospholipids of other hepatoma cell lines (HuH-7, Hep-G2, and huL-1) which were not associated with hepatitis B virus (HBV) infection, were composed mostly of 1,2-diacylglycerophospholipids. Activities of dihydroxyacetone-phosphate acyltransferase, which is known to be an obligatory enzyme in ether lipid biosynthesis, were found to be elevated by three- to fourfold in both huGK-14 and PLC/PRF/5 cells compared to those of other hepatoma cell lines. The results suggest a possible relationship between HBV-induced hepatocellular carcinogenesis and the drastic change in the metabolism of membrane phospholipids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169517

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.

Authors:  Andreas Merz; Gang Long; Marie-Sophie Hiet; Britta Brügger; Petr Chlanda; Patrice Andre; Felix Wieland; Jacomine Krijnse-Locker; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

Review 3.  Host factors involved in hepatitis B virus maturation, assembly, and egress.

Authors:  Reinhild Prange
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

4.  Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.

Authors:  Sebastian Zeissig; Kazumoto Murata; Lindsay Sweet; Jean Publicover; Zongyi Hu; Arthur Kaser; Esther Bosse; Jahangir Iqbal; M Mahmood Hussain; Katharina Balschun; Christoph Röcken; Alexander Arlt; Rainer Günther; Jochen Hampe; Stefan Schreiber; Jody L Baron; D Branch Moody; T Jake Liang; Richard S Blumberg
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

5.  The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment.

Authors:  Hongde Li; Wandi Zhu; Leike Zhang; Hehua Lei; Xiangyu Wu; Lin Guo; Xinwen Chen; Yulan Wang; Huiru Tang
Journal:  Sci Rep       Date:  2015-02-12       Impact factor: 4.379

6.  Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.

Authors:  Tao Wu; Xiaojiao Zheng; Ming Yang; Aihua Zhao; Meng Li; Tianlu Chen; Jun Panee; Wei Jia; Guang Ji
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

7.  Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease.

Authors:  Ismael Dale Cotrim Guerreiro da Silva; Erica Valadares de Castro Levatti; Amanda Paula Pedroso; Dirce Maria Lobo Marchioni; Antonio Augusto Ferreira Carioca; Gisele Wally Braga Colleoni
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Novel transmembrane topology of the hepatitis B virus envelope proteins.

Authors:  R Prange; R E Streeck
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

9.  Metabolic characterization of the natural progression of chronic hepatitis B.

Authors:  Johannes C Schoeman; Jun Hou; Amy C Harms; Rob J Vreeken; Ruud Berger; Thomas Hankemeier; Andre Boonstra
Journal:  Genome Med       Date:  2016-06-10       Impact factor: 11.117

Review 10.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.